Testing effectiveness (Phase 2)Ended earlyNCT03986996What this trial is testingAntimicrobial Therapy for Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Wolfson Medical Center 20
Early research (Phase 1)Study completedNCT02159989What this trial is testingSapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00044018What this trial is testingCDC-501 Therapy in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 102
Early research (Phase 1)UnknownNCT04295018What this trial is testingBCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaWho this might be right forMultiple Myeloma Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02509546What this trial is testing8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia City of Hope Medical Center 20
Early research (Phase 1)Looking for participantsNCT05963217What this trial is testingStudy of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLWho this might be right forRelapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma University Health Network, Toronto 19
Testing effectiveness (Phase 2)Study completedNCT00002474What this trial is testingCombination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian CancerWho this might be right forOvarian Cancer Loyola University
Testing effectiveness (Phase 2)Study completedNCT00144690What this trial is testingE2007 Given as Adjunctive Therapy in Patients With Refractory Partial SeizuresWho this might be right forEpilepsy Eisai Inc.
Not applicableLooking for participantsNCT06678282What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ LeukemiaWho this might be right forB-NHLB-ALL Shenzhen Genocury Biotech Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06960759What this trial is testingMechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic CoughWho this might be right forChronic Cough (CC)Refractory Chronic CoughUnexplained Chronic Cough University of Montana 135
Early research (Phase 1)Ended earlyNCT03547115What this trial is testingVoruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLWho this might be right forFollicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more MEI Pharma, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT03449082What this trial is testingTreatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)Who this might be right forLateral Epicondylitis Seoul National University Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02134262What this trial is testingGene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesWho this might be right forRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma Jichi Medical University 18
Early research (Phase 1)Looking for participantsNCT07025564What this trial is testingMiRisten for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT03770416What this trial is testingNivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System LymphomaWho this might be right forCentral Nervous System B-Cell Non-Hodgkin LymphomaRecurrent Central Nervous System LymphomaRefractory Central Nervous System Lymphoma M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT03548207What this trial is testingJNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 126
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02311023What this trial is testingIntermittent Fasting in Refractory EpilepsyWho this might be right forEpilepsy University College London Hospitals 4